FDA Approves New Molecularly Targeted Therapeutic for Non-Hodgkin Lymphoma
The flurry of treatments approved by the U.S. Food and Drug Administration (FDA) for treating hematological malignancies continued last...
The flurry of treatments approved by the U.S. Food and Drug Administration (FDA) for treating hematological malignancies continued last...
A half marathon is a challenging goal for anyone. Several members of the American Association for Cancer Research (AACR)...
Among the many types of cancer acknowledged during the month of September is lymphoma, a cancer arising from a...